Source: Asian Venture Capital Journal

CPC Diagnostics: Everstone's healthcare platform makes first India investment

Everlife, an Asia healthcare investment platform managed by India's Everstone Group, has made its first investment in India, committing an undisclosed amount to medical device manufacturer CPC Diagnostics.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Pramod Kabra's photo - CEO of CPC Diagnostics

CEO

Pramod Kabra

CEO Approval Rating

- -/100

Read more